| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |